Nest Genomics Company Profile

Background

Nest Genomics, founded in 2022, is a health technology company dedicated to integrating genomic data into mainstream clinical practice. The company's mission is to simplify the incorporation of genetic information into healthcare workflows, thereby enhancing personalized patient care. By providing a comprehensive, lab-agnostic platform, Nest Genomics enables health systems, clinics, pharmaceutical companies, and payors to launch and scale longitudinal genomic programs effectively.

Key Strategic Focus

Nest Genomics focuses on developing Electronic Medical Records (EMR)-integrated solutions that facilitate the seamless incorporation of genomics into clinical practice. Their platform offers clinical decision support tools to help providers create patient care plans based on the latest clinical guidelines and patient information. Additionally, the solution includes patient engagement tools that empower individuals to understand and manage their genetic information over time.

Financials and Funding

In January 2023, Nest Genomics closed an $8.5 million seed financing round led by B Capital, with participation from Y Combinator, Casdin Capital, DCVC, Samsung Next, Maven Ventures, iAngels, Arkin Digital Health, LionBird, Anne Wojcicki, and Deneen Vojta. The funds are intended to support product launches with additional customers, integration with more EMRs, and expansion into other clinical specialty areas, including pediatrics, polygenic risk scores, and pharmacogenetics.

Technological Platform and Innovation

Nest Genomics offers a HIPAA-compliant, lab-agnostic software platform designed to launch, implement, and scale longitudinal genomic programs. The platform integrates with existing EMR systems, allowing providers to access decision support directly at the point of care. It includes patient engagement tools that empower individuals to understand and manage their genetic information over time. The platform's modular design allows customization to fit the unique needs of various healthcare organizations.

Leadership Team

Moran Snir, Co-Founder and Chief Executive Officer: Moran has a background in promoting genetic testing and previously co-founded Clear Genetics, which was acquired by Invitae in 2019.

Guy Snir, Co-Founder and Chief Operating Officer: Guy has held senior product roles at Twitter, SnappyTV, and Google's Motorola subsidiary.

Competitor Profile

Market Insights and Dynamics

The genomics industry is experiencing rapid growth, driven by advancements in sequencing technologies and increasing adoption of personalized medicine. The integration of genomic data into clinical workflows is becoming a critical component of modern healthcare, with a focus on improving patient outcomes through tailored treatment plans.

Competitor Analysis

10x Genomics: Specializes in gene sequencing technology used in scientific research, offering products that enable high-resolution analysis of biological systems.

DNAnexus: Provides a cloud-based data analysis and management platform for DNA sequence data, facilitating large-scale genomic data processing and collaboration.

Helix: Focuses on personal genomics and citizen science, offering a marketplace for DNA-powered products and services, and operates a sequencing laboratory.

Strategic Collaborations and Partnerships

Genome Medical: In January 2025, Nest Genomics partnered with Genome Medical to scale access to genetic services and improve patient care. This collaboration combines Genome Medical's clinical genetics expertise with Nest Genomics' scalable platform to offer comprehensive genetic services integrated into clinical workflows.

athenahealth: In October 2024, Nest Genomics joined athenahealth's Marketplace Program, integrating its platform to bring the power of genomics to the point of care. This integration allows healthcare providers using athenahealth's network to access Nest's comprehensive EHR-integrated solution for genomic-based care.

Operational Insights

Nest Genomics differentiates itself by offering a comprehensive, EMR-integrated platform that addresses the entire patient journey in genomic care. Its modular design allows healthcare organizations to tailor the platform to their specific needs, facilitating the seamless integration of genetic information into existing clinical workflows. This approach enhances provider efficiency and patient engagement, positioning Nest Genomics as a valuable partner in the adoption of personalized medicine.

Strategic Opportunities and Future Directions

With the recent seed funding, Nest Genomics plans to expand its product offerings to additional customers, integrate with more EMR systems, and venture into other clinical specialty areas such as pediatrics, polygenic risk scores, and pharmacogenetics. By continually enhancing its platform and forming strategic partnerships, Nest Genomics aims to play a pivotal role in the widespread adoption of genomic data in clinical practice, ultimately improving patient outcomes through personalized care.